As professor Berni Canani points out, postbiotics expand the frontiers of gastroenterology.
The use of inactivated bacteria to prevent gastrointestinal tract infections - but also upper respiratory tract infections - increases the safety of the treatment. The new generation of products will permit to have more control on the doses, the mechanism of action and the reproducibility of the effect of this strategy against gastrointestinal infections in the child.